Press release: invIOs goes live
invIOs goes live with unique cell therapy platform and clinical-stage immuno-oncology pipeline Vienna, Austria, 16 December 2021: invIOs (innovative Immuno-Oncology) GmbH, a privately held biotechnology company developing novel therapies for…
December 15, 2021
No Comments
Press release: APEIRON Biologics launches next clinical trial with innovative cancer therapy APN401
Important development step for promising cell therapy Paradigm shift in cancer treatment: process developed by APEIRON uses immune system to treat solid tumors Innovative new manufacturing and treatment process enables…
July 6, 2021
No Comments
Press release: APEIRON Biologics announces changes to management and supervisory boards
Management Board to be expanded by Romana Gugenberger, PhD, as Chief Medical & Scientific Officer (CMSO) and Andreas Gerber, PhD, as Chief Operating Officer (COO) Prof. Josef Penninger moves from…
June 1, 2021
No Comments
